Table 1 Demographics and outcome of the patients
Variables | Placebo | Diclofenac | Silodosin | Silodosin + Diclofenac | p value |
|---|---|---|---|---|---|
Group A | Group B | Group C | Group D | ||
Mean ± SD age in years | 34.7 ± 10.8 | 36.4 ± 13.5 | 32.3 ± 9.9 | 40.2 ± 9.8 | 0.17 |
Sex M/F | 40/13 | 45/11 | 36/15 | 42/16 | 0.38 |
Diagnosis | |||||
Ureteric stone | 47 | 51 | 48 | 49 | 0.26 |
Renal stone | 6 | 5 | 3 | 9 | |
Side | |||||
Left | 28 | 18 | 21 | 31 | 0.90 |
Right | 25 | 38 | 30 | 27 | |
Mean ± SD duration of stenting in days | 23.5 ± 3.7 | 25.4 ± 2.6 | 21.7 ± 2.3 | 22.5 ± 2.8 | 0.06 |
A–C (0.01) | |||||
Mean ± SD pre-stent removal VAS score | 3.4 ± 0.9 | 3.5 ± 0.9 | 3.7 ± 1.0 | 3.2 ± 0.8 | 0.98 |
Mean ± SD post stent removal VAS score | 4.2 ± 1.3 | 2.9 ± 1.1 | 3.1 ± 1.2 | 2.8 ± 1.0 | <0.001 B–A (<0.001) C–A (<0.001) D–A (<0.001) |
Post stent removal VAS score | |||||
≤5 | 44 | 53 | 46 | 57 | 0.35 |
>5 | 9 | 3 | 5 | 2 | |
Mean ± SD additional analgesics requirement in mg (i.v morphine equivalents) | 9 ± 0.7 | 4 ± 0.9 | 6 ± 0.8 | 3 ± 1.1 | 0.07 |